Skip to content
AnalystLens

Leidos Holdings Annual Report, Year Ended Jan 30, 2015

Filing Date
Filed March 25, 2015
Period End
January 30, 2015
Security
LDOS
In the record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’18Aug ’18
  2. Leadership change8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Feb ’23Feb ’23
  4. Material agreement8-K · Feb ’25Feb ’25

Summary

Summary of the 10-K filed March 25, 2015. Cited figures are marked; the original filing is the authoritative source.

Leidos Holdings, Inc. reported fiscal 2015 (ended January 30, 2015) revenues of $5.06 billiona, down 12% from $5.76 billion in fiscal 2014, and swung to an operating loss of $214 million from operating income of $163 million the prior year.

The loss was driven primarily by $486 millionb of goodwill impairment charges in the Health and Engineering segment, along with $41 million of intangible asset impairments and a $40 million tangible asset impairment tied to the Plainfield renewable energy plant. Net loss was $323 million, or $(4.36) per diluted share, compared with net income of $164 million the prior year. The company states that about 79% of total revenues came from U.S. Government contracts, with the Department of Defense representing approximately 67%.

The National Security Solutions segment remained the larger contributor, with revenues of $3.59 billionc (down 11%) and operating income of $286 million. Health and Engineering revenues fell 14% to $1.49 billion and posted an operating loss of $472 million. Total backlog declined to $7.8 billion from $9.3 billion, and net bookings were approximately $3.6 billion versus $4.9 billion a year earlier.

Cash and cash equivalents ended the year at $443 milliond, and operating cash flow from continuing operations rose to $396 million from $191 million. The company paid $95 million in dividends, repurchased $215 million of stock, and retired $175 million of debt. The filing also discloses that Leidos agreed on March 24, 2015 to sell its Plainfield biomass plant, a transaction that is partially seller-financed.

The company additionally notes a pending $44 million arbitral award against the Greek government that was annulled by an Athens appeals court, and a $123 million cumulative loss recorded on that contract. Management stated that its existing cash, operating cash flows and $500 million revolving facility are sufficient for at least the next 12 months.

Key Highlights

  1. Revenues were $5.06 billion in fiscal 2015, down 12% from $5.76 billion, with National Security Solutions down 11% and Health and Engineering down 14%.
  2. Operating loss of $214 million compared with operating income of $163 million in fiscal 2014, primarily due to $486 million of goodwill impairment charges and $81 million of asset impairment charges.
  3. Net loss of $323 million, or $(4.36) per diluted share, versus net income of $164 million in fiscal 2014.
  4. Total backlog fell to $7.8 billion from $9.3 billion, and net bookings were approximately $3.6 billion versus $4.9 billion the prior year.
  5. Approximately 79% of total revenues came from U.S. Government contracts, with the DoD accounting for approximately 67%.
  6. Operating cash flow from continuing operations increased to $396 million from $191 million, and cash ended the year at $443 million.
  7. Agreed in March 2015 to sell the Plainfield biomass plant, which the company had acquired through a foreclosure in fiscal 2014; the transaction is partially seller-financed.

Follow one dollar

For each $1.00 of revenue in FY2015, Leidos Holdings lost $0.07.

  1. Revenue$4.69B100.0%
  2. Cost of revenue−$4.07B86.8%
  3. Gross profit$621.0M13.2%
  4. Operating costs−$812.0M17.3%
  5. Operating income−$191.0M4.1%
  6. Interest, other & tax−$132.0M2.8%
  7. Net income−$323.0M6.9%
Computed from 10-KFY2015filed March 25, 2015Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

FY2015 against FY2014

Line itemFY2015FY2014Change
Revenue$4.69B$5.75B−18.5%
Cost of Revenue$4.07B$4.99B−18.5%
Gross Profit$621.00M$763.00M−18.6%
R&D Expenses$37.00M$45.00M−17.8%
SG&A Expenses$280.00M$440.00M−36.4%
Operating Income-$191.00M$163.00M−217.2%
Interest Expense$71.00M$82.00M−13.4%
Net Income-$323.00M$161.00M−300.6%
EPS (Basic)$-4.51$1.94−332.5%
EPS (Diluted)$-4.51$1.94−332.5%
Shares Outstanding (Basic)74.00M83.00M−10.8%
Shares Outstanding (Diluted)74.00M83.00M−10.8%

Frequently Asked Questions

  1. Why did Leidos report an operating loss in fiscal 2015?

    The company recorded $486 million of goodwill impairment charges in its Health Solutions and Engineering reporting units during the second quarter, after declines in forecasted revenue and delayed award decisions. It also recorded $41 million of intangible asset impairments and a $40 million impairment on the Plainfield plant's tangible assets, which together drove the operating loss of $214 million.

  2. How did the company's segments perform?

    National Security Solutions revenues fell 11% to $3.59 billion, with operating income of $286 million, down 2%. Health and Engineering revenues fell 14% to $1.49 billion and reported an operating loss of $472 million, compared with operating income of $20 million the prior year. Corporate and Other operating loss narrowed to $28 million from $149 million.

  3. What drove the decline in revenue?

    The filing attributes the National Security Solutions decline primarily to the drawdown of overseas U.S. military forces ($320 million) and the ramp-down of the Joint Logistics Integration program ($82 million), along with sequestration and budget cuts. Health and Engineering revenue fell mainly due to lower hospital electronic health record implementations ($82 million) and the completion of an international Army support contract in security products ($39 million).

  4. What is the status of the Greek government contract and the Plainfield plant?

    The company holds a $44 million arbitral award against the Hellenic Republic of Greece, which the Athens Court of Appeals annulled in June 2014; Leidos appealed to the Supreme Court of Greece in January 2015 and continues enforcement in U.S. District Court, and the outcomes are described as uncertain. The company has recorded $123 million of cumulative losses on the contract. For Plainfield, a definitive agreement to sell the plant was signed in March 2015, with completion expected in the first half of the next fiscal year.